Sumel Ashique
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 18
- Nanoparticle-Based Drug Delivery 15
- Food Science 20
- Probiotics and Fermented Foods 17
- Co-authors
- Neeraj Mishra (44 shared papers)Ashish Garg (26 shared papers)Afzal Hussain (26 shared papers)Navjot Kaur Sandhu (8 shared papers)Radheshyam Pal (21 shared papers)Farzad Taghizadeh‐Hesary (20 shared papers)Himanshu Sharma (12 shared papers)Shubneesh Kumar (23 shared papers)
- Journals
- Infectious Disorders - Drug Targets (7 papers)Current Pharmaceutical Design (6 papers)Inflammopharmacology (5 papers)Current Nanoscience (4 papers)Drug Discovery Today (4 papers)
- Partner nations
- IndiaSaudi ArabiaPakistan
In The Last Decade
Sumel Ashique
169 papers receiving 2.1k citations
Sumel Ashique's Hit Papers
Peers
Comparison fields: 5 of 101
- Biomaterials 235
- Drug Discovery 1
- Pharmaceutical Science 74
- Molecular Biology 336
- Food Science 87
Countries citing papers authored by Sumel Ashique
This map shows the geographic impact of Sumel Ashique's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumel Ashique with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumel Ashique more than expected).
Fields of papers citing papers by Sumel Ashique
This network shows the impact of papers produced by Sumel Ashique. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumel Ashique. The network helps show where Sumel Ashique may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumel Ashique, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 114 | |
| 2 | 2022 | 110 | |
| 3 | A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer Hit paper breakdown → | 2023 | 100 |
| 4 | Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success Hit paper breakdown → | 2024 | 98 |
| 5 | Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation Hit paper breakdown → | 2024 | 85 |
| 6 | 2023 | 72 | |
| 7 | 2024 | 65 | |
| 8 | 2023 | 59 | |
| 9 | 2022 | 50 | |
| 10 | 2023 | 46 | |
| 11 | 2024 | 42 | |
| 12 | 2022 | 40 | |
| 13 | 2023 | 37 | |
| 14 | 2024 | 36 | |
| 15 | 2024 | 36 | |
| 16 | 2020 | 35 | |
| 17 | 2023 | 35 | |
| 18 | 2023 | 35 | |
| 19 | 2023 | 34 | |
| 20 | 2022 | 33 |
About Sumel Ashique
Sumel Ashique is a scholar working on Biomaterials, Food Science, Molecular Biology, Pharmaceutical Science and Infectious Diseases, having authored 218 papers that have together received 2.2k indexed citations. Recurring topics across this work include Probiotics and Fermented Foods (17 papers), Nanoparticle-Based Drug Delivery (15 papers), Gut microbiota and health (12 papers), Extracellular vesicles in disease (10 papers), Nanoparticles: synthesis and applications (6 papers), Advancements in Transdermal Drug Delivery (6 papers), Protein Degradation and Inhibitors (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Biomaterials (235 citations), Drug Discovery (1 citation), Pharmaceutical Science (74 citations), Molecular Biology (336 citations) and Food Science (87 citations). Sumel Ashique has collaborated with scholars based in India, Saudi Arabia and Pakistan. Frequent co-authors include Neeraj Mishra, Ashish Garg, Afzal Hussain, Navjot Kaur Sandhu, Radheshyam Pal, Farzad Taghizadeh‐Hesary, Himanshu Sharma, Shubneesh Kumar, Kamal Dua and Pooja A. Chawla. Their work appears in journals such as Infectious Disorders - Drug Targets, Current Pharmaceutical Design, Inflammopharmacology, Current Nanoscience and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.